رجوع
نطاق اليوم
KWD 61.41
KWD 64.25
نطاق 52 أسبوعًا
KWD 45.00
KWD 85.84
حجم التداول
660,334
متوسط 50 يوم / 200 يوم
KWD 69.11
/
KWD 69.40
الإغلاق السابق
KWD 61.49
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -256.9 | 0.4 |
| P/B | 4.4 | 2.9 |
| ROE % | -1.9 | 3.8 |
| Net Margin % | -0.9 | 3.9 |
| Rev Growth 5Y % | 11.6 | 10.0 |
| D/E | 1.7 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 92.000
+49.0%
Low: KWD 90.000
High: KWD 95.000
مكرر الربحية المستقبلي
97.7
ربحية السهم المستقبلية
KWD 0.632
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
2.5 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2028 |
KWD 1.180
KWD 1.133 – KWD 1.227
|
3 B | 2 |
| FY2027 |
KWD 1.010
KWD 0.804 – KWD 1.216
|
2.7 B | 3 |
| FY2026 |
KWD 0.632
KWD 0.387 – KWD 0.849
|
2.5 B | 3 |
النقاط الرئيسية
Revenue grew 11.60% annually over 5 years — strong growth
Earnings declined -767.81% over the past year
Generating 85.57M in free cash flow
PEG of 0.38 suggests growth is underpriced
ROIC of 2.31% — low return on invested capital
Interest coverage of 1.30× — tight debt servicing
النمو
Revenue Growth (5Y)
11.60%
Revenue (1Y)11.51%
Earnings (1Y)-767.81%
FCF Growth (3Y)39.04%
الجودة
Return on Equity
-1.87%
ROIC2.31%
Net Margin-0.91%
Op. Margin4.45%
الأمان
Debt / Equity
1.71
Current Ratio1.76
Interest Coverage1.30
التقييم
P/E Ratio
-256.90
P/B Ratio4.40
EV/EBITDA64.79
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11.51% | Revenue Growth (3Y) | 12.34% |
| Earnings Growth (1Y) | -767.81% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11.60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.04B | Net Income (TTM) | -18.65M |
| ROE | -1.87% | ROA | -0.50% |
| Gross Margin | 4.45% | Operating Margin | 4.45% |
| Net Margin | -0.91% | Free Cash Flow (TTM) | 85.57M |
| ROIC | 2.31% | FCF Growth (3Y) | 39.04% |
| Safety | |||
| Debt / Equity | 1.71 | Current Ratio | 1.76 |
| Interest Coverage | 1.30 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -256.90 | P/B Ratio | 4.40 |
| P/S Ratio | 2.35 | PEG Ratio | 0.38 |
| EV/EBITDA | 64.79 | Dividend Yield | 0.00% |
| Market Cap | 4.79B | Enterprise Value | 5.88B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.04B | 1.83B | 1.62B | 1.43B | 1.32B |
| Net Income | -18.65M | 2.79M | 3.04M | 10.65M | 24.73M |
| EPS (Diluted) | -0.25 | 0.04 | 0.05 | 0.17 | 0.46 |
| Gross Profit | 90.80M | 249.12M | 221.39M | 165.72M | 191.80M |
| Operating Income | 90.80M | 104.62M | 98.70M | 46.36M | 82.55M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.76B | 3.29B | 2.69B | 2.43B | 2.06B |
| Total Liabilities | 2.40B | 2.15B | 1.88B | 1.94B | 1.71B |
| Shareholders' Equity | 1.09B | 902.31M | 630.70M | 333.00M | 228.90M |
| Total Debt | 1.86B | 1.73B | 1.49B | 1.51B | 1.40B |
| Cash & Equivalents | 767.22M | 740.02M | 342.57M | 127.83M | 134.61M |
| Current Assets | 1.03B | 1.02B | 579.28M | 367.18M | 324.26M |
| Current Liabilities | 586.76M | 479.71M | 437.45M | 466.72M | 374.78M |